Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)

v3.21.2
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Statement of Comprehensive Income [Abstract]        
Revenue $ 24,045 $ 15,639 $ 64,584 $ 47,514
Cost of revenue 10,330 6,319 26,729 21,316
Gross profit 13,715 9,320 37,855 26,198
Operating expenses        
Sales and marketing 10,399 4,982 25,711 16,744
Research and development 9,761 4,031 21,487 12,883
General and administrative 15,935 3,889 32,770 11,138
Total operating expenses 36,095 12,902 79,968 40,765
Loss from operations (22,380) (3,582) (42,113) (14,567)
Change in fair value of warrant liabilities 1,418 (66) 170 (79)
Change in fair value of contingent earnout liability 42,710 42,710
Other (expense) income, net (48) (25) (168) 11
Interest expense (6) (23) (15) (51)
Interest income 6 3 9 146
Profit (loss) before income taxes 21,700 (3,693) 593 (14,540)
Income tax (benefit) expense (3) 26 (1) 113
Net profit (loss) and comprehensive income (loss) $ 21,703 $ (3,719) $ 594 $ (14,653)
Weighted average shares outstanding - Basic 162,942,990 38,545,607 81,373,265 38,149,992
Weighted average shares outstanding - diluted 167,091,320 38,545,607 85,407,166 38,149,992
Net profit (loss) per share - basic $ 0.13 $ (0.10) $ 0.01 $ (0.38)
Net profit (loss) per share - diluted $ 0.13 $ (0.10) $ 0.01 $ (0.38)